Resource Library
Do you know of a resource that would be a great addition to our collection? Let us know!
Search results
Letter from Free the Pill coalition steering committee to Perrigo
“As cost remains the top challenge for consumer access, it is incumbent upon all of us to remain committed to eliminating barriers to contraceptive equity and to work as hard as we can to create a fair and equitable marketplace for all. Now, more than ever, we must prioritize contraceptive equity—and for Opill, that means fulfilling Perrigo’s promise to set an affordable price and establish a robust consumer assistance program that allows everyone to benefit from this groundbreaking advancement in reproductive health.”
— Free the Pill coalition steering committee
Comment from Ibis Reproductive Health on Request for Information: Coverage of Over-the-Counter Preventive Services
“OTC coverage is key to equitable access and in the case of contraceptive care, it is also a reproductive justice issue. We know that barriers to contraception fall harder on communities that experience systemic inequities due to structural racism, bias, and other forms of oppression, and it is imperative that policies are designed to break down these barriers, not uphold them.”
— Kelly Blanchard, Robyn Elliott, Victoria Nichols, and Britt Wahlin
Comment from Free the Pill coalition on Request for Information: Coverage of Over-the-Counter Preventive Services
“We urge the Administration to require insurance coverage of OTC contraception without a prescription requirement and without cost sharing. This is a vitally important path to ensuring the accessibility of Opill, particularly for those who face the most barriers to accessing reproductive health care.”
— Free the Pill coalition
Letter from Free the Pill coalition to Departments of HHS, Labor, and Treasury
“The FDA’s recent approval of a progestin-only pill as the first-ever OTC birth control pill has the potential to increase access for many who need birth control and face barriers to accessing prescription products. As Opill hits store shelves in early 2024, we must ensure that it’s affordable and accessible to everyone who wants or needs it.”
— Free the Pill coalition
Letter from Free the Pill coalition to FDA Commissioner Dr. Robert M. Califf
“The FDA must prioritize reviewing the first-ever application for an OTC birth control pill and announce a new date for the advisory committee meeting as soon as possible.”
— Free the Pill coalition
Letter from OCs OTC Working Group to FDA Commissioner Dr. Robert M. Califf
“The potential benefits here are enormous and have been documented through decades of research and data on the benefits of birth control access for all… The public support reflects the benefits of access as well: seventy percent of women of reproductive age are in favor of making birth control available over the counter without a prescription.”
— Oral Contraceptives (OCs) Over-the-Counter (OTC) Working Group
Letter from Pro-Choice Caucus to FDA Commissioner Dr. Robert M. Califf
“Despite decades of proven safety and effectiveness, people still face immense barriers to getting birth control due to systemic inequities in our healthcare system… FDA has an important role to play in removing unnecessary barriers to provide individuals greater control over their reproductive lives and health.”
— Pro-Choice Caucus, United States House of Representatives